Journal of International Oncology››2023,Vol. 50››Issue (7): 407-412.doi:10.3760/cma.j.cn371439-20230404-00079
• Original Articles •Previous ArticlesNext Articles
Wu Minhang1, Sun Wenzheng2, Yu Qingzhuo2, Guo Rong2, Ye Hui3, Du Ying3, Qiu Jin2, An Huazhang2(), Cao Lili1,2,3(
)
Received:
2023-04-04Revised:
2023-06-03Online:
2023-07-08Published:
2023-08-03Contact:
Cao Lili,Email:
Wu Minhang, Sun Wenzheng, Yu Qingzhuo, Guo Rong, Ye Hui, Du Ying, Qiu Jin, An Huazhang, Cao Lili. RNF43 inhibits PD-L1 expressionviaβ-catenin in melanoma cells and promotes CD8+T cell-mediated anti-tumor immune reaction[J]. Journal of International Oncology, 2023, 50(7): 407-412.
[1] | National Health Commission of the People’s Republic of China. Chinese guidelines for diagnosis and treatment of melanoma 2018 (English version)[J]. Chin J Cancer Res, 2019, 31(4): 578-585. DOI: 10.21147/j.issn.1000-9604.2019.04.02. doi:10.21147/j.issn.1000-9604.2019.04.02 |
[2] | Herbst RS, Soria JC, Kowanetz M, et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients[J]. Nature, 2014, 515(7528): 563-567. DOI: 10.1038/nature14011. doi:10.1038/nature14011 |
[3] | Tsukiyama T, Zou J, Kim J, et al. A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis[J]. Nat Commun, 2020, 11(1): 4586. DOI: 10.1038/s41467-020-18257-3. doi:10.1038/s41467-020-18257-3pmid:32934222 |
[4] | Tsukiyama T, Fukui A, Terai S, et al. Molecular role of RNF43 in canonical and noncanonical Wnt signaling[J]. Mol Cell Biol, 2015, 35(11): 2007-2023. DOI: 10.1128/MCB.00159-15. doi:10.1128/MCB.00159-15pmid:25825523 |
[5] | Neumeyer V, Grandl M, Dietl A, et al. Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells[J]. Carcinogenesis, 2019, 40(4): 551-559. DOI: 10.1093/carcin/bgy152. doi:10.1093/carcin/bgy152pmid:30380024 |
[6] | Sakamoto H, Kuboki Y, Hatori T, et al. Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas[J]. Mod Pathol, 2015, 28(2): 261-267. DOI: 10.1038/modpathol.2014.98. doi:10.1038/modpathol.2014.98 |
[7] | Luo H, Ma C. Identification of prognostic genes in uveal melanoma microenvironment[J]. PLoS One, 2020, 15(11): e0242263. DOI: 10.1371/journal.pone.0242263. doi:10.1371/journal.pone.0242263 |
[8] | Radaszkiewicz T, Nosková M, Gömöryová K, et al. RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy[J]. Elife, 2021, 10: e65759. DOI: 10.7554/eLife.65759. doi:10.7554/eLife.65759 |
[9] | Gajos-Michniewicz A, Czyz M. WNT signaling in melanoma[J]. Int J Mol Sci, 2020, 21(14): 4852. DOI: 10.3390/ijms21144852. doi:10.3390/ijms21144852 |
[10] | Martínez-Lostao L, Anel A, Pardo J. How do cytotoxic lymphocytes kill cancer cells?[J]. Clin Cancer Res, 2015, 21(22): 5047-5056. DOI: 10.1158/1078-0432.CCR-15-0685. doi:10.1158/1078-0432.CCR-15-0685pmid:26567364 |
[11] | Alspach E, Lussier DM, Schreiber RD. Interferon γ and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity[J]. Cold Spring Harb Perspect Biol, 2019, 11(3): a028480. DOI: 10.1101/cshperspect.a028480. doi:10.1101/cshperspect.a028480 |
[12] | Du L, Lee JH, Jiang H, et al. β-catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion[J]. J Exp Med, 2020, 217(11): e20191115. DOI: 10.1084/jem.2019 1115. doi:10.1084/jem.2019 |
[1] | Hong Anlan, Cao Meng, Wang Yan, Fang Fang.Research progress on lncRNAs as members of ceRNA network in melanoma[J]. Journal of International Oncology, 2022, 49(1): 61-64. |
[2] | Wang Qian, Tan Xiaojun, Zhang Donghui, Luo Kai.Application of β-catenin, Cyclin D1 and DKK1 in pathologically aided diagnosis of breast cancer[J]. Journal of International Oncology, 2021, 48(7): 402-408. |
[3] | Zhang Ruizhi, Chen Xin, Zhang Peng, Tao Kaixiong.New progress on diagnosis and treatment of anorectal malignant melanoma[J]. Journal of International Oncology, 2020, 47(6): 377-380. |
[4] | Du Mingli, Li Guixiang, Wu Wenjuan, Zhao Lei.Application of circulating tumor DNA in targeted therapy and immunotherapy of metastatic melanoma[J]. Journal of International Oncology, 2020, 47(6): 381-384. |
[5] | Jin Lan, Kang Xiaojing.Drug resistance mechanism and treatment strategy for targeted therapy of melanoma[J]. Journal of International Oncology, 2018, 45(7): 444-448. |
[6] | Miao Qiuju, Wang Yifei, Xu Xiulian..Molecular targeted therapy in malignant melanoma[J]. Journal of International Oncology, 2018, 45(11): 699-702. |
[7] | Xia Dechun, Kang Xiaojing.Role and mechanism of Notch signaling pathway in melanoma growth and metastasis[J]. Journal of International Oncology, 2018, 45(10): 635-638. |
[8] | Wang Yanjun, Kang Xiaojing.Biomarkers for malignant melanoma[J]. Journal of International Oncology, 2018, 45(1): 59-. |
[9] | Chai Li, Kang Xiaojing.Non-coding small RNA and melanoma[J]. Journal of International Oncology, 2017, 44(7): 541-543. |
[10] | Sun Chengyu, Xu Yuqing.Immunotherapy in melanoma patients with autoimmune disease[J]. Journal of International Oncology, 2017, 44(4): 310-312. |
[11] | He Yan, Tie Jun, Tang Jun.Role of microphthalmia-associated transcription factor in melanoma metastasis[J]. Journal of International Oncology, 2017, 44(4): 281-283. |
[12] | Tang Jianqin, Hou Xiaoyang, Jiang Guan, Wei Zhiping, Liu Yanqun.Application of nanotechnology in the diagnosis and therapy of melanoma[J]. Journal of International Oncology, 2016, 43(11): 871-873. |
[13] | Qiu Wangwang, Yang Zhili, Zheng Qi.Ring finger protein 43 gene and its function in digestive system cancer[J]. Journal of International Oncology, 2016, 43(1): 56-59. |
[14] | Wang Shixiong, Li Yaoping.Ring finger protein 43 gene and cancer[J]. Journal of International Oncology, 2016, 43(1): 23-25. |
[15] | MA Ya-Nan, WANG Bao-Hong, SU Qing-Hong, XU Xiao-Qun, WANG Jun-Fu.Effect of miR27a on cell proliferation and apoptosis in human melanoma cell line WM239[J]. Journal of International Oncology, 2015, 42(3): 161-164. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||